Review
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Dec 27, 2023; 15(12): 2674-2692
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2674
Table 2 Geographical distribution of the surgical site infections’ incidence
Continent
Country
Period
SSIs incidence
Ref.
AfricaCameroon2013-2014Overall: 15.25%[23]
Egypt2013-2017CSEC: 5.34%[24]
2016-2018Overall: 2.3%, CSEC: 2.8%[25]
Ethiopia2015Overall: 19.1%[26]
2019Overall: 21.1%; ABDS: 49.06%[27]
Ghana2017-2018Overall: 10%; APPY: 13.4%; GAST: 12.7%; HER: 5.9%; ABDS: 13.7%[28]
Kenya2015CSEC: 4%[29]
Morocco2018-2019Overall: 6.3%[30]
Rwanda2019-2020CSEC: 5.7%[31]
Sierra Leone2019-2020CSEC: 10.3%; HER: 1.2%[32]
2021Overall: 11.5%; ABDS: 79.5%[33]
South Africa2017APPY: 25%[34]
Tanzania2009-2010Overall: 26%; APPY: 15%; CHOL: 14.3%; XLAP: 27.9%[35]
2018-2020CSEC: 14%[36]
Tunisia2015-2016CSEC: 5%[37,38]
2015APPY: 9.8%; CHOL: 1.1%; BILI: 13.6%
AmericaBrazil2008-2011Overall: 3.4%[39]
2008-2018BAR open: 3%; BAR VLP: 0.5%[40]
Canada2015-2016CSEC: 5.9%[41]
2015-2019COLO: 10.28%; BILI: 16.13%[42]
Colombia2008-2010APPY: 3.9%; HYST: 5.5%; SPLE: 4.5%; CHOL: 3%[43]
2022HER: 7.9%; CHOL: 8.3%; CSEC: 22.2%[44]
Cuba2017-2018APPY: 13.8%; HER: 5.7%[45]
Ecuador2018CSEC: 1.35%[46]
Honduras2017-2018CSEC: 5.1%[47]
Mexico2011-2012Overall: 12.1%; COLO: 5.2%; APPY: 4.9%; CHOL: 0.8%; HER: 0.9%[48]
2013-2015CHOL: 5.5%[49]
Peru2005-2010APPY: 2.9%; CHOL: 2.8%; CSEC: 2.2%[50]
2015-2018CSEC: 2.4%[51]
2019-2020CSEC: 0.88%; CHOL: 0.18%; HER: 0.38%[52]
Uruguay2012-2013APPY: 3.2%; CHOL: 6.2%; COLO: 15.4%[53]
2021CSEC: 1.74%; CHOL open: 1.85%; CHOL VLP: 0.23%[54]
Venezuela2019-2021Overall: 9.7%; APPY: 10.42%; BILI 3.79%[55]
United States2011-2014Overall: 0.9%; COLO: 3.99%-9.47%; CHOLO: 0.23%-1.72%; HER: 0.74%-5.25%; REC: 3.47%-26.67%; SB: 3.44%-6.75%[16,17,56]
2015-2019COLO: 6.82%; BILI: 12.72%[42]
2016-2017CHOL: 0.96%[57]
AsiaChina2020ABDS: 2.9%; COLO 7.1%[58,59]
2018GAST: 5.2%[60]
2017-2020CSEC: 23.30%[61]
India2011-2017Appendix: 35.3%[62]
2016CSEC: 10.3%[63]
2005-2011XLAP: 6%; HER: 3.8%[64]
Iran2018Overall: 0.29%[65]
2021Overall: 5.2% surveillance[66]
Japan2008-2010COLO: 15%; REC: 17.8%[67,68]
2009-2019APPY: VLP 4.19%, OPEN 6.60%[69]
CHOL: VLP 1.91%, OPEN 7.42%
SB: VLP 8%, OPEN 15%
COLO: VLP 7.27%, OPEN 15.5%
REC: VLP 11.3%, OPEN 8.8%
Kuwait2016SB: 6.5%; GAST: 0.7%[70]
Nepal2019CSEC: 8.54%[71]
Pakistan2014-2019BILI: 40%[72]
2016-2017APPY: 32.7%; CHOLO: 20.7%; HER: 37.6%[73]
Philippines2018-2019Overall: 9.7%[74]
Republic of Korea2008-2012GAST: 3.12%[75]
Saudi Arabia2016Overall: 16.3%; open surgery: 34.8%; VLP surgery: 3.5%[76]
Taiwan2021Overall: 4.0%; regional hospital: 4.7% medical center[77]
Thailand2007-2016Overall: 2.98%[78]
Turkey2005-2011CHOL: 1.3%; COLO: 11.4%; CSEC: 3%; GAST: 4.3%; HYST: 3.1%; SPLE: 5%; XLAP: 2.6%[79]
United Arab Emirates2016-2017CSEC: 1.4%[80]
EuropeAustria2018-2020CHOL: 0.4%; COLO: 3.6%; CSEC: 0.5%[19]
England2017-2022HYST: 1.7%; BILI: 15.4%; CHOL: 9.7%; GAST: 1.9%; COLO: 8.6%[81]
Estonia2018-2020CSEC: 2.0%[19]
France2018-2020CHOL: 0.7%; CSEC: 1.7%[19]
Germany2018-2020CHOL: 0.9%; COLO: 8.9%; CSEC: 0.6%[19]
Hungary2018-2020CHOL: 1.1%; COLO: 10.4%; CSEC: 1.3%[19]
Italy2018-2020CHOL: 0.7%; COLO: 5.9%; CSEC: 0.7%[19]
Lithuania2018-2020CHOL: 0.2%; COLO: 10.6%; CSEC: 0.6%[19]
Malta2018-2020COLO: 26.8%[19]
Netherlands2018-2020CHOL: 2.6%; COLO: 16.1%; CSEC: 1.5%[19]
Norway2018-2020CHOL: 2.8%; COLO: 11.7%; CSEC: 3.6%[19]
Portugal2018-2020CHOL: 2.3%; COLO: 14.5%; CSEC: 1.6%[19]
Slovakia2018-2020CHOL: 2.9%[19]
Spain2016COLO: 10.6%[82]
2013-2016REC: 11.9%[83]
2009-2016CHOL: 1.96%[84]
Switzerland2017-2018APPY: 3.1%; CHOL: 2.2%; HER: 0.9%; COLO: 13.5%; REC: 17.7%; GAST: 3.1%; CSEC: 1.8%[85]
OceaniaAustralia2002-2013Overall: 2.8%[86]